Russell Investments Group
WHWK

Russell Investments Group’s Whitehawk Therapeutics WHWK Stock Holding History

Russell Investments Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33K Hold
386
– – ﹤0.01% 4039
2025
Q4 		$934 Hold
386
– – ﹤0.01% 4051
2025
Q3 		$733 Hold
386
– – ﹤0.01% 4065
2025
Q2 		$722 Sell
386
-1,126
-74% -$1.96K ﹤0.01% 3706
2025
Q1 		$2.69K Hold
1,512
– – ﹤0.01% 3470
2024
Q4 		$4.77K Hold
1,512
– – ﹤0.01% 3298
2024
Q3 		$3.12K Buy
+1,512
New +$2.44K ﹤0.01% 3308
2024
Q2 		– Sell
-970
Closed -$2.27K – 3632
2024
Q1 		$2.27K Buy
+970
New +$1.87K ﹤0.01% 3057
2023
Q3 		– Sell
-266
Closed -$1.82K – 3642
2023
Q2 		$1.82K Buy
266
+171
+180% +$1.33K ﹤0.01% 3257
2023
Q1 		$688 Buy
+95
New +$1.01K ﹤0.01% 3073
2021
Q1 		– Sell
-1,373
Closed -$20K – 3204
2020
Q4 		$20K Hold
1,373
– – ﹤0.01% 2983
2020
Q3 		$30K Buy
+1,373
New +$28.9K ﹤0.01% 3119

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Russell Investments Group's WHWK Position: Q1 2026 in Review

Russell Investments Group held its Whitehawk Therapeutics (WHWK) position steady in Q1 2026 at 386 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

Russell Investments Group first reported a position in WHWK in Q3 2020 and has held it in 12 quarters since. The position peaked at $30K in Q3 2020. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Russell Investments Group held 386 shares of Whitehawk Therapeutics worth $1.33K as of Q1 2026.
  • Russell Investments Group left its Whitehawk Therapeutics share count unchanged in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #4039 holding.
  • Russell Investments Group first reported a position in Whitehawk Therapeutics in Q3 2020 and has held it in 12 quarters since.
  • Russell Investments Group's Whitehawk Therapeutics position peaked at $30K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.